David G. Hattan

664 total citations
13 papers, 512 citations indexed

About

David G. Hattan is a scholar working on Food Science, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David G. Hattan has authored 13 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Food Science, 3 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in David G. Hattan's work include Neuroscience and Neuropharmacology Research (3 papers), Immunotoxicology and immune responses (2 papers) and Melamine detection and toxicity (2 papers). David G. Hattan is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Immunotoxicology and immune responses (2 papers) and Melamine detection and toxicity (2 papers). David G. Hattan collaborates with scholars based in United States. David G. Hattan's co-authors include Denise M. Sailstad, William S. Stokes, Richard N. Hill, Raymond R. Tice, Lorraine E. Twerdok, Jack H. Dean, Teresa G. Cachero, Anthony D. Morielli, Greg R. Olson and Gonçalo Gamboa da Costa and has published in prestigious journals such as Journal of Biological Chemistry, Life Sciences and Neuropharmacology.

In The Last Decade

David G. Hattan

13 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David G. Hattan United States 10 187 134 125 122 103 13 512
Erwin van Vliet Belgium 13 118 0.6× 70 0.5× 24 0.2× 158 1.3× 115 1.1× 19 463
Jochen Kühnl Germany 14 240 1.3× 37 0.3× 14 0.1× 90 0.7× 77 0.7× 22 532
J Tyler Ramsey United States 9 16 0.1× 89 0.7× 57 0.5× 7 0.1× 81 0.8× 10 311
R. Roll Germany 8 5 0.0× 63 0.5× 40 0.3× 28 0.2× 66 0.6× 18 324
Alicia Penissi Argentina 14 11 0.1× 5 0.0× 45 0.4× 5 0.0× 134 1.3× 30 517
Ezra Berman United States 16 4 0.0× 162 1.2× 16 0.1× 33 0.3× 67 0.7× 35 664
Kelly Dong United States 9 205 1.1× 12 0.1× 13 0.1× 2 0.0× 104 1.0× 10 421
L. Manzo Italy 11 9 0.0× 127 0.9× 55 0.4× 8 0.1× 118 1.1× 30 445
M.C. Holroyde Canada 11 10 0.1× 21 0.2× 7 0.1× 13 0.1× 102 1.0× 20 531
B. Marignac France 10 7 0.0× 41 0.3× 8 0.1× 12 0.1× 45 0.4× 15 257

Countries citing papers authored by David G. Hattan

Since Specialization
Citations

This map shows the geographic impact of David G. Hattan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Hattan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Hattan more than expected).

Fields of papers citing papers by David G. Hattan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Hattan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Hattan. The network helps show where David G. Hattan may publish in the future.

Co-authorship network of co-authors of David G. Hattan

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Hattan. A scholar is included among the top collaborators of David G. Hattan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Hattan. David G. Hattan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Costa, Gonçalo Gamboa da, Linda S. Von Tungeln, Greg R. Olson, et al.. (2012). Dose–response assessment of nephrotoxicity from a twenty-eight-day combined-exposure to melamine and cyanuric acid in F344 rats. Toxicology and Applied Pharmacology. 262(2). 99–106. 36 indexed citations
2.
Reimschuessel, Renate, Linda S. Von Tungeln, Greg R. Olson, et al.. (2010). Dose-Response Assessment of Nephrotoxicity from a 7-Day Combined Exposure to Melamine and Cyanuric Acid in F344 Rats. Toxicological Sciences. 119(2). 391–397. 52 indexed citations
3.
Hattan, David G., et al.. (2002). Current developments in food additive toxicology in the USA. Toxicology. 181-182. 417–420. 2 indexed citations
4.
Hattan, David G., et al.. (2002). Tyrosine Phosphorylation of Kv1.2 Modulates Its Interaction with the Actin-binding Protein Cortactin. Journal of Biological Chemistry. 277(41). 38596–38606. 61 indexed citations
5.
Dean, Jack H., Lorraine E. Twerdok, Raymond R. Tice, et al.. (2001). ICCVAM Evaluation of the Murine Local Lymph Node Assay. Regulatory Toxicology and Pharmacology. 34(3). 258–273. 103 indexed citations
6.
Duffy, P. H., John E. Seng, Sherry M. Lewis, et al.. (2001). The effects of different levels of dietary restriction on aging and survival in the Sprague-Dawley rat: Implications for chronic studies. Aging Clinical and Experimental Research. 13(4). 263–272. 46 indexed citations
7.
Sailstad, Denise M., David G. Hattan, Richard N. Hill, & William S. Stokes. (2001). ICCVAM Evaluation of the Murine Local Lymph Node Assay. Regulatory Toxicology and Pharmacology. 34(3). 249–257. 117 indexed citations
8.
Freeman, G. B., Tomáš Sobotka, & David G. Hattan. (1990). Acute Effects of Aspartame on Concentrations of Brain Amines and their Metabolites in Selected Brain Regions of Fischer 344 and Sprague-Dawley Rats. Drug and Chemical Toxicology. 13(2-3). 113–133. 8 indexed citations
9.
Hattan, David G., et al.. (1986). FDA's Priority-Based Assessment of Food Additives. Regulatory Toxicology and Pharmacology. 6(2). 181–191. 23 indexed citations
10.
Hattan, David G., et al.. (1985). FDA's Priority-Based Assessment of Food Additives. Regulatory Toxicology and Pharmacology. 5(2). 152–174. 26 indexed citations
11.
Hattan, David G., et al.. (1984). FDA's priority-based assessment of food additives I. Preliminary results. Regulatory Toxicology and Pharmacology. 4(1). 37–56. 16 indexed citations
12.
Hattan, David G. & Patrick I. Eacho. (1978). Relationship of ethanol blood level to REM and non-REM sleep time and distribution in the rat. Life Sciences. 22(10). 839–845. 13 indexed citations
13.
Hattan, David G. & Harald Wolf. (1977). Effects of intrahypothalamic 6-hydroxydopamine on central thermoregulatory responses to (+)- and (-)-norepinephrine and dopamine. Neuropharmacology. 16(10). 639–648. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026